ADULT ACUTE MYELOMONOCYTIC LEUKEMIA
Clinical trials for ADULT ACUTE MYELOMONOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ADULT ACUTE MYELOMONOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for ADULT ACUTE MYELOMONOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested to fight leukemia in seniors
Disease control OngoingThis study tested a combination of two drugs, azacitidine and gemtuzumab ozogamicin, to treat older adults with a type of blood cancer called acute myeloid leukemia (AML). The goal was to see if this combination was safe and effective enough to put patients into remission and war…
Matched conditions: ADULT ACUTE MYELOMONOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New strategy aims to make leukemia cells more vulnerable to chemo
Disease control OngoingThis study is testing whether adding a drug called decitabine before standard chemotherapy helps treat acute myeloid leukemia (AML) more effectively. The goal is to see if decitabine can 'prime' or sensitize the cancer cells, making them easier for the chemotherapy drugs to kill.…
Matched conditions: ADULT ACUTE MYELOMONOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 11, 2026 14:54 UTC